Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025)

Legend Biotech filings provide 6 years of Other Working Capital Changes readings, the most recent being -$10.3 million for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 39.29% to -$10.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$45.9 million, a 22.34% decrease, with the full-year FY2022 number at -$50.6 million, down 4207.57% from a year prior.
  • Other Working Capital Changes hit -$10.3 million in Q3 2025 for Legend Biotech, down from -$9.5 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $16.1 million in Q2 2021 to a low of -$50.6 million in Q4 2022.
  • Median Other Working Capital Changes over the past 5 years was -$5.6 million (2021), compared with a mean of -$7.5 million.
  • Biggest five-year swings in Other Working Capital Changes: soared 121.43% in 2023 and later tumbled 135244.44% in 2024.
  • Legend Biotech's Other Working Capital Changes stood at -$3.0 million in 2021, then crashed by 1606.47% to -$50.6 million in 2022, then skyrocketed by 100.02% to $9000.0 in 2023, then crashed by 189433.33% to -$17.0 million in 2024, then soared by 39.29% to -$10.3 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$10.3 million (Q3 2025), -$9.5 million (Q2 2025), and -$9.0 million (Q1 2025) per Business Quant data.